Homeobox Genes in Cancers: From Carcinogenesis to Recent Therapeutic Intervention

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Nov 1

PMID 34722321

Citations 35

Authors

Yangyang Feng

Tongyue Zhang

Yijun Wang

Meng Xie

Xiaoyu Ji

Xiangyuan Luo

Wenjie Huang

Limin Xia

Affiliations

Soon will be listed here.

Abstract

The homeobox (HOX) genes encoding an evolutionarily highly conserved family of homeodomain-containing transcriptional factors are essential for embryogenesis and tumorigenesis. HOX genes are involved in cell identity determination during early embryonic development and postnatal processes. The deregulation of HOX genes is closely associated with numerous human malignancies, highlighting the indispensable involvement in mortal cancer development. Since most HOX genes behave as oncogenes or tumor suppressors in human cancer, a better comprehension of their upstream regulators and downstream targets contributes to elucidating the function of HOX genes in cancer development. In addition, targeting HOX genes may imply therapeutic potential. Recently, novel therapies such as monoclonal antibodies targeting tyrosine receptor kinases, small molecular chemical inhibitors, and small interfering RNA strategies, are difficult to implement for targeting transcriptional factors on account of the dual function and pleiotropic nature of HOX genes-related molecular networks. This paper summarizes the current state of knowledge on the roles of HOX genes in human cancer and emphasizes the emerging importance of HOX genes as potential therapeutic targets to overcome the limitations of present cancer therapy.

Citing Articles

The HOX code of human adult fibroblasts reflects their ectomesenchymal or mesodermal origin.

Pfeiferova L, Spanko M, Sachova J, Hradilova M, Pienta K, Valach J Histochem Cell Biol. 2025; 163(1):38.

PMID: 40063181 PMC: 11893657. DOI: 10.1007/s00418-025-02362-9.

Global chromatin reorganization and regulation of genes with specific evolutionary ages during differentiation and cancer.

Raynal F, Sengupta K, Plewczynski D, Aliaga B, Pancaldi V Nucleic Acids Res. 2025; 53(4).

PMID: 39964480 PMC: 11833689. DOI: 10.1093/nar/gkaf084.

The HOX Gene Family's Role as Prognostic and Diagnostic Biomarkers in Hematological and Solid Tumors.

Kopec K, Quaranto D, DeSouza N, Jarboe T, Islam H, Moscatello A Cancers (Basel). 2025; 17(2).

PMID: 39858044 PMC: 11763641. DOI: 10.3390/cancers17020262.

The homeobox family gene signature predicts the prognosis of osteosarcoma and correlates with immune invasion.

Liu W, Xia K, Huang X, Wei Z, Wei Z, Guo W Sci Rep. 2025; 15(1):886.

PMID: 39762460 PMC: 11704140. DOI: 10.1038/s41598-024-84924-w.

STUB1 suppresses paclitaxel resistance in ovarian cancer through mediating HOXB3 ubiquitination to inhibit PARK7 expression.

Zhao L, Yang H, Wang Y, Yang S, Jiang Q, Tan J Commun Biol. 2024; 7(1):1439.

PMID: 39501077 PMC: 11538469. DOI: 10.1038/s42003-024-07127-z.

References

Li Y, Ren Y, Wang Y, Tan Y, Wang Q, Cai J . A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. Theranostics. 2019; 9(16):4608-4623. PMC: 6643429. DOI: 10.7150/thno.35188. View

Cantile M, di Bonito M, Cerrone M, Collina F, De Laurentiis M, Botti G . Long Non-Coding RNA in Breast Cancer Therapy. Cancers (Basel). 2020; 12(5). PMC: 7281113. DOI: 10.3390/cancers12051197. View

Feng W, Huang W, Chen J, Qiao C, Liu D, Ji X . CXCL12-mediated HOXB5 overexpression facilitates Colorectal Cancer metastasis through transactivating CXCR4 and ITGB3. Theranostics. 2021; 11(6):2612-2633. PMC: 7806482. DOI: 10.7150/thno.52199. View

Zhou L, Wang Y, Zhou M, Zhang Y, Wang P, Li X . HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development. Nat Commun. 2018; 9(1):1480. PMC: 5902613. DOI: 10.1038/s41467-018-03914-5. View

Whelan J, Ludwig D, Bertrand F . HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia. 2008; 22(6):1161-9. DOI: 10.1038/leu.2008.57. View

Wang H, Jia X, Chen J, Yi Y, Wang J, Li Y . HOXB4 knockdown reverses multidrug resistance of human myelogenous leukemia K562/ADM cells by downregulating P-gp, MRP1 and BCRP expression via PI3K/Akt signaling pathway. Int J Oncol. 2016; 49(6):2529-2537. DOI: 10.3892/ijo.2016.3738. View

Lee D, Forscher C, Di Vizio D, Koeffler H . Induction of p53-independent apoptosis by ectopic expression of HOXA5 in human liposarcomas. Sci Rep. 2015; 5:12580. PMC: 4518222. DOI: 10.1038/srep12580. View

Grier D, Thompson A, Kwasniewska A, McGonigle G, Halliday H, Lappin T . The pathophysiology of HOX genes and their role in cancer. J Pathol. 2005; 205(2):154-71. DOI: 10.1002/path.1710. View

Shah N, Jin K, Cruz L, Park S, Sadik H, Cho S . HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression. Cancer Res. 2013; 73(17):5449-58. PMC: 3967590. DOI: 10.1158/0008-5472.CAN-13-1178. View

10.

Ewing C, Ray A, Lange E, Zuhlke K, Robbins C, Tembe W . Germline mutations in HOXB13 and prostate-cancer risk. N Engl J Med. 2012; 366(2):141-9. PMC: 3779870. DOI: 10.1056/NEJMoa1110000. View

11.

Gilbert P, Mouw J, Unger M, Lakins J, Gbegnon M, Clemmer V . HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Invest. 2010; 120(5):1535-50. PMC: 2860938. DOI: 10.1172/JCI39534. View

12.

Liu S, Jin K, Hui Y, Fu J, Jie C, Feng S . HOXB7 promotes malignant progression by activating the TGFβ signaling pathway. Cancer Res. 2014; 75(4):709-19. PMC: 4352303. DOI: 10.1158/0008-5472.CAN-14-3100. View

13.

Kroon E, Krosl J, Thorsteinsdottir U, Baban S, Buchberg A, Sauvageau G . Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 1998; 17(13):3714-25. PMC: 1170707. DOI: 10.1093/emboj/17.13.3714. View

14.

Quagliata L, Matter M, Piscuoglio S, Arabi L, Ruiz C, Procino A . Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. 2013; 59(3):911-23. PMC: 3943759. DOI: 10.1002/hep.26740. View

15.

Barresi V, Ieni A, Cardia R, Licata L, Vitarelli E, Reggiani Bonetti L . HOXB13 as an immunohistochemical marker of prostatic origin in metastatic tumors. APMIS. 2015; 124(3):188-93. DOI: 10.1111/apm.12483. View

16.

Li P, Chen P, Peng X, Ma C, Zhang W, Dai X . HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition. Aging (Albany NY). 2018; 10(1):115-130. PMC: 5811246. DOI: 10.18632/aging.101363. View

17.

Ding W, Zhou M, Chen M, Qu C . HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer. J Cancer Res Clin Oncol. 2016; 143(3):385-397. DOI: 10.1007/s00432-016-2283-4. View

18.

Teo W, Merino V, Cho S, Korangath P, Liang X, Wu R . HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24. Oncogene. 2016; 35(42):5539-5551. PMC: 5073039. DOI: 10.1038/onc.2016.95. View

19.

Liu Z, Chen Z, Fan R, Jiang B, Chen X, Chen Q . Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer. Mol Cancer. 2017; 16(1):82. PMC: 5405470. DOI: 10.1186/s12943-017-0651-6. View

20.

Lin J, Zhu H, Hong L, Tang W, Wang J, Hu H . Coexpression of HOXA6 and PBX2 promotes metastasis in gastric cancer. Aging (Albany NY). 2021; 13(5):6606-6624. PMC: 7993744. DOI: 10.18632/aging.202426. View